Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua

NCT06036030 is registered in ClinicalTrials.gov with Syamsudin Abdillah,Ph.D, Pharm D as lead sponsor.

NCT NCT06036030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06036030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua
Lead sponsor
Syamsudin Abdillah,Ph.D, Pharm D
Phase
Phase 2
Overall status
Completed
Start date
January 11, 2019
Completion date
April 16, 2019
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infections, malaria, malaria, vivax, malaria,falciparum, uncomplicated malaria, uncomplicated plasmodium falciparum